SCSangeeta S. Chavan

Sangeeta S. Chavan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sangeeta S. Chavan has a total of 265 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bed nucleus of the stria terminalis neurons encode and retrieve cytokine-specific responses in male mice

    by Okito Hashimoto, Tyler D. Hepler, Aisling Tynan, Alejandro Torres, Jian Hua Li, Michael Brines, Kevin J. Tracey, Sangeeta S. Chavan

  • Top Cited Papers
    Open Access

    Central neurons encode interleukin-1β signals and mediate stress-induced inflammation

    by Okito Hashimoto, Tyler D. Hepler, Aisling Tynan, Alejandro Torres, Jian Hua Li, Michael Brines, Kevin J. Tracey, Sangeeta S. Chavan

    The brain encodes and stores information about peripheral inflammation and can directly recapitulate prior inflammatory responses. However, whether individual cytokines activate specific neural circuits to produce distinct physiological responses remains unknown. To address this fundamental question, we mapped brain-wide responses to IL-1β and found prominent engagement of the bed nucleus of the stria terminalis (BNST). Using targeted recombination in active populations, snRNA sequencing, and circuit tracing, we discovered that corticotropin-releasing hormone-expressing BNST neurons encode IL-1β signals. Chemogenetic reactivation of these neurons precisely recapitulates the physiological signatures of IL-1β exposure with increased circulating IL-6 and corticosterone and tachycardia. These responses require a defined BNST→paraventricular nucleus→rostral ventrolateral medulla→β receptor adrenergic signaling pathway. Critically, restraint stress also activates these BNST IL-1β–encoding neurons to generate the same physiological responses. Our findings establish how a single inflammatory mediator uses a precise neural circuit to activate systemic responses and provide mechanistic insight into the neuroimmune interactions underlying stress-related psychiatric and inflammatory diseases.


  • Top Cited Papers
    Open Access

    Neural representation of cytokines by vagal sensory neurons

    by Tomás S. Huerta, Adrian C. Chen, Saher Chaudhry, Aisling Tynan, Timothy Morgan, Kicheon Park, Richard Adamovich-Zeitlin, Bilal Haider, Jian Hua Li, Mitali Nagpal, et al.

    The nervous system coordinates with the immune system to detect and respond to harmful stimuli. Inflammation is a universal response to injury and infection that involves the release of cytokines. While it is known that information about cytokines is transmitted from the body to the brain, how the nervous system encodes specific cytokines in the form of neural activity is not well understood. Using in vivo calcium imaging, we show that vagal sensory neurons within the nodose ganglia exhibit distinct real-time neuronal responses to inflammatory cytokines. Some neurons respond selectively to individual cytokines, while others encode multiple cytokines with distinct activity patterns. In male mice with induced colitis, inflammation increased the baseline activity of these neurons but decreased responsiveness to specific cytokines, reflecting altered neural excitability. Transcriptomic analysis of vagal ganglia from colitis mice revealed downregulation of cytokine signaling pathways, while neuronal activity pathways were upregulated. Thus, nodose ganglia neurons perform real-time encoding of cytokines at the first neural station in a body-brain axis, providing a new framework for studying the dynamic nature of neuroimmune communication.


  • Open Access

    TRPV1 nociceptors are required to optimize antigen-specific primary antibody responses to novel antigens

    by Aisling Tynan, Téa Tsaava, Manojkumar Gunasekaran, Carlos E. Bravo Iñiguez, Michael Brines, Sangeeta S. Chavan, Kevin J. Tracey

    Background: Key to the advancement of the field of bioelectronic medicine is the identification of novel pathways of neural regulation of immune function. Sensory neurons (termed nociceptors) recognize harmful stimuli and initiate a protective response by eliciting pain and defensive behavior. Nociceptors also interact with immune cells to regulate host defense and inflammatory responses. However, it is still unclear whether nociceptors participate in regulating primary IgG antibody responses to novel antigens. Methods: To understand the role of transient receptor potential vanilloid 1 (TRPV1)-expressing neurons in IgG responses, we generated TRPV1-Cre/Rosa-ChannelRhodopsin2 mice for precise optogenetic activation of TRPV1 + neurons and TRPV1-Cre/Lox-diphtheria toxin A mice for targeted ablation of TRPV1-expressing neurons. Antigen-specific antibody responses were longitudinally monitored for 28 days. Results: Here we show that TRPV1 expressing neurons are required to develop an antigen-specific immune response. We demonstrate that selective optogenetic stimulation of TRPV1+ nociceptors during immunization significantly enhances primary IgG antibody responses to novel antigens. Further, mice rendered deficient in TRPV1- expressing nociceptors fail to develop primary IgG antibody responses to keyhole limpet hemocyanin or haptenated antigen. Conclusion: This functional and genetic evidence indicates a critical role for nociceptor TRPV1 in antigen-specific primary antibody responses to novel antigens. These results also support consideration of potential therapeutic manipulation of nociceptor pathways using bioelectronic devices to enhance immune responses to foreign antigens.


  • Open Access

    Correction: Galantamine ameliorates experimental pancreatitis

    by Dane A. Thompson, Tea Tsaava, Arvind Rishi, Sam J. George, Tyler D. Hepler, Daniel Hide, Valentin A. Pavlov, Michael Brines, Sangeeta S. Chavan, Kevin J. Tracey

  • Open Access

    Circulating extracellular choline acetyltransferase regulates inflammation

    by Arielle H. Gabalski, Aisling Tynan, Tea Tsaava, Jian Hua Li, Diana Lee, Tyler D. Hepler, Daniel Hide, Sam George, Carlos E. Bravo Iñiguez, Dane A Thompson, et al.

    Background: Choline acetyltransferase (ChAT) is required for the biosynthesis of acetylcholine, the molecular mediator that inhibits cytokine production in the cholinergic anti‐inflammatory pathway of the vagus nerve inflammatory reflex. Abundant work has established the biology of cytoplasmic ChAT in neurons, but much less is known about the potential presence and function of ChAT in the extracellular milieu.Objectives: We evaluated the hypothesis that extracellular ChAT activity responds to inflammation and serves to inhibit cytokine release and attenuate inflammation.Methods: After developing novel methods for quantification of ChAT activity in plasma, we determined whether ChAT activity changes in response to inflammatory challenges.Results: Active ChAT circulates within the plasma compartment of mice and responds to immunological perturbations. Following the administration of bacterial endotoxin, plasma ChAT activity increases for 12–48 h, a time period that coincides with declining tumor necrosis factor (TNF) levels. Further, a direct activation of the cholinergic anti‐inflammatory pathway by vagus nerve stimulation significantly increases plasma ChAT activity, whereas the administration of bioactive recombinant ChAT (r‐ChAT) inhibits endotoxin‐stimulated TNF production and anti‐ChAT antibodies exacerbate endotoxin‐induced TNF levels, results of which suggest that ChAT activity regulates endogenous TNF production. Administration of r‐ChAT significantly attenuates pro‐inflammatory cytokine production and disease activity in the dextran sodium sulfate preclinical model of inflammatory bowel disease. Finally, plasma ChAT levels are also elevated in humans with sepsis, with the highest levels observed in a patient who succumbed to infection.Conclusion: As a group, these results support further investigation of ChAT as a counter‐regulator of inflammation and potential therapeutic agent.


  • Open Access

    Galantamine ameliorates experimental pancreatitis

    by Dane A. Thompson, Tea Tsaava, Arvind Rishi, Sam J. George, Tyler D. Hepler, Daniel Hide, Valentin A. Pavlov, Michael Brines, Sangeeta S. Chavan, Kevin J. Tracey

    Background: Acute pancreatitis is a common and serious inflammatory condition currently lacking disease modifying therapy. The cholinergic anti-inflammatory pathway (CAP) is a potent protective anti-inflammatory response activated by vagus nerve-dependent α7 nicotinic acetylcholine receptor (α7nAChR) signaling using splenic CD4+ T cells as an intermediate. Activating the CAP ameliorates experimental acute pancreatitis. Galantamine is an acetylcholinesterase inhibitor (AChEI) which amplifies the CAP via modulation of central muscarinic ACh receptors (mAChRs). However, as mAChRs also activate pancreatitis, it is currently unknown whether galantamine would be beneficial in acute pancreatitis. Methods: The effect of galantamine (1–6 mg/kg-body weight) on caerulein-induced acute pancreatitis was evaluated in mice. Two hours following 6 hourly doses of caerulein (50 µg/kg-body weight), organ and serum analyses were performed with accompanying pancreatic histology. Experiments utilizing vagotomy, gene knock out (KO) technology and the use of nAChR antagonists were also performed. Results: Galantamine attenuated pancreatic histologic injury which was mirrored by a reduction in serum amylase and pancreatic inflammatory cytokines and an increase the anti-inflammatory cytokine IL-10 in the serum. These beneficial effects were not altered by bilateral subdiaphragmatic vagotomy, KO of either choline acetyltransferase+ T cells or α7nAChR, or administration of the nAChR ganglionic blocker mecamylamine or the more selective α7nAChR antagonist methyllycaconitine. Conclusion: Galantamine improves acute pancreatitis via a mechanism which does not involve previously established physiological and molecular components of the CAP. As galantamine is an approved drug in widespread clinical use with an excellent safety record, our findings are of interest for further evaluating the potential benefits of this drug in patients with acute pancreatitis.


  • Open Access

    Comparative evaluation of anti-bacterial effect of Caesalpinia sappan aqueous extract and 0.12% Chlorhexidine against Streptococcus mutans – An in vitro study

    by Madhivathani S M, Umesh K, Sangeeta Chavan, Palanivel Pandian R, Prem Kumar P

    Aim and objectives: To evaluate and compare the antimicrobial activity of various concentration of C.sappan wood aqueous extract (100mg/ml, 200mg/ml, 300mg/ml, 400mg/ml, 500mg/ml and 600mg/ml) and 0.12% chlorhexidine mouthwash using agar well diffusion method against St.mutans. Materials and Methods: A comparative experimental invitro study was conducted to evaluate and compare antimicrobial activity of various concentration of C.Sappan aqueous extract and 0.12% Chlorhexidine. The study enclosed extract of 100mg/ml, 200mg/ml, 300mg/ml, 400mg/ml, 500mg/ml, 600mg/ml and 0.12% Chlorhexidine as control. The antimicrobial activity was assessed by agar well diffusion method, were 50µl of each concentration was poured in the prepared agar well and assessed for zone of inhibition. Results: The antimicrobial potential of test compounds was estimated by measuring the zone of inhibition and all the procedure are done in triplicates and values are assessed using One way ANOVA and Post Hoc analysis. All the concentration used showed zone of inhibition against St.mutans. At the concentration, 600mg/ml of aqueous C.sappan extract have a larger zone of inhibition (22.41±.32). In agar well diffusion method, at the minimal concentration of 600mg/ml and C.Sappan aqueous extract was comparatively better than positive control group (0.12%cholorhexidine). Conclusion: C.Sappan wood aqueous extract could be preferred for routine oral hygiene practice where it can provide maximal antimicrobial effect without side effects of routine aid.

  • Open Access

    Vagus nerve stimulation primes platelets and reduces bleeding in hemophilia A male mice

    by Carlos E. Bravo-Iñiguez, Jason R. Fritz, Shilpa Shukla, Susmita Sarangi, Dane A. Thompson, Seema G. Amin, Tea Tsaava, Saher Chaudhry, Sara P. Valentino, Hannah B. Hoffman, et al.

    Deficiency of coagulation factor VIII in hemophilia A disrupts clotting and prolongs bleeding. While the current mainstay of therapy is infusion of factor VIII concentrates, inhibitor antibodies often render these ineffective. Because preclinical evidence shows electrical vagus nerve stimulation accelerates clotting to reduce hemorrhage without precipitating systemic thrombosis, we reasoned it might reduce bleeding in hemophilia A. Using two different male murine hemorrhage and thrombosis models, we show vagus nerve stimulation bypasses the factor VIII deficiency of hemophilia A to decrease bleeding and accelerate clotting. Vagus nerve stimulation targets acetylcholine-producing T lymphocytes in spleen and α7 nicotinic acetylcholine receptors (α7nAChR) on platelets to increase calcium uptake and enhance alpha granule release. Splenectomy or genetic deletion of T cells or α7nAChR abolishes vagal control of platelet activation, thrombus formation, and bleeding in male mice. Vagus nerve stimulation warrants clinical study as a therapy for coagulation disorders and surgical or traumatic bleeding.


  • Open Access

    Electrical stimulation of the dorsal motor nucleus of the vagus regulates inflammation without affecting the heart rate

    by Aidan Falvey, Santhoshi P. Palandira, Sangeeta S. Chavan, Michael Brines, Kevin J. Tracey, Valentin A. Pavlov

    Background The vagus nerve plays an important role in neuroimmune interactions and in the regulation of inflammation. A major source of efferent vagus nerve fibers that contribute to the regulation of inflammation is the brainstem dorsal motor nucleus of the vagus (DMN) as recently shown using optogenetics. In contrast to optogenetics, electrical neuromodulation has broad therapeutic implications, but the anti-inflammatory efficacy of electrical DMN stimulation (eDMNS) was not previously investigated. Here, we examined the effects of eDMNS on heart rate (HR) and cytokine levels in murine endotoxemia as well as the cecal ligation and puncture (CLP) model of sepsis. Methods Anesthetized male 8–10-week-old C57BL/6 mice on a stereotaxic frame were subjected to eDMNS using a concentric bipolar electrode inserted into the left or right DMN or sham stimulation. eDMNS (50, 250 or 500 μA and 30 Hz, for 1 min) was performed and HR recorded. In endotoxemia experiments, sham or eDMNS utilizing 250 μA or 50 μA was performed for 5 mins and was followed by LPS (0.5 mg/kg) i.p. administration. eDMNS was also applied in mice with cervical unilateral vagotomy or sham operation. In CLP experiments sham or left eDMNS was performed immediately post CLP. Cytokines and corticosterone were analyzed 90 mins after LPS administration or 24h after CLP. CLP survival was monitored for 14 days. Results Either left or right eDMNS at 250 μA and 500 μA decreased HR, compared with pre- and post-stimulation. This effect was not observed at 50 μA. Left side eDMNS at 50 μA, compared with sham stimulation, significantly decreased serum and splenic levels of the pro-inflammatory cytokine TNF and increased serum levels of the anti-inflammatory cytokine IL-10 during endotoxemia. The anti-inflammatory effect of eDMNS was abrogated in mice with unilateral vagotomy and were not associated with serum corticosterone alterations. Right side eDMNS suppressed serum TNF levels but had no effects on serum IL-10 and on splenic cytokines. In mice with CLP, left side eDMNS suppressed serum TNF and IL-6, as well as splenic IL-6 and increased splenic IL-10 and significantly improved the survival rate of CLP mice. Conclusions For the first time we show that a regimen of eDMNS which does not cause bradycardia alleviates LPS-induced inflammation and these effects require an intact vagus nerve and are not associated with corticosteroid alterations. eDMNS also decreases inflammation and improves survival in a model of polymicrobial sepsis. These findings are of interest for further studies exploring bioelectronic anti-inflammatory approaches targeting the brainstem DMN.